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Purpose: To evaluate the diagnostic performance of maternal inflammatory mark-
er: C-reactive protein (CRP) in predicting early onset neonatal sepsis (that occur-
ring within 72 hours after birth). Materials and Methods: 126 low birth weight 
newborns (gestation 32±3.2 wk, birth weight 1887±623 g) and their mothers were 
included. Neonates were divided into sepsis group (n=51) including both proven 
(positive blood culture) and suspected (negative blood culture but with more than 
3 abnormal clinical signs), and controls (n=75). Mothers were subgrouped into 
CRP positive ≥1.22 mg/dL (n=48) and CRP negative <1.22 mg/dL (n=78) group, 
determined by Receiver Operating Characteristic curves, and odds ratio was calcu-
lated for neonatal sepsis according to maternal condition. Results: Maternal CRP 
was significantly higher in neonatal sepsis group than in control (3.55±2.69 vs. 
0.48±0.31 mg/dL, p=0.0001). Maternal CRP (cutoff value >1.22 mg/dL) had sen-
sitivity 71% and specificity 84% for predicting neonatal sepsis. Maternal CRP pos-
itive group had more neonatal sepsis than CRP negative group (71% vs. 29%, 
p<0.001). Odds ratio of neonatal sepsis in maternal CRP positive group versus 
CRP negative group was 10.68 (95% confidence interval: 4.313-26.428, p<0.001). 
Conclusion: The risk of early onset neonatal sepsis significantly increased in the 
case of positive maternal CRP (≥1.22 mg/dL). In newborn of CRP positive moth-
er, the clinician may be alerted to earlier evaluation for possible neonatal infection 
prior to development of sepsis.
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INTRODUCTION
Maternal and peripartum risk factors influence early onset neonatal sepsis. The 
most frequent risk factors are chorioamnionitis and maternal systemic infection.1,2 
Intrauterine infection increases morbidity and mortality of diseases such as severe 
maternal infectious shock, disseminated intravascular coagulopathy, adult respira-
tory distress syndrome (RDS), and renal failure.3 Also, intrauterine infection and 
inflammation induce preterm labor at least one-third of spontaneous preterm deli-
veres.4,5 The 12.7% of all pregnancies is preterm birth in the United States. Preterm 
birth is responsible for 75% of perinatal mortality and more than half the long-
term morbidity of survivors.6 The birth of preterm infants increases neonatal sep-
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days of birth;17 1) longer than 1 hour of unstable body tem-
perature (axillary temperature: fever >37.5°C, hypothermia 
<36.5°C), 2) cardiovascular abnormality (heart rate <100, 
or >160 per minute, hypotension requiring inotropics), 3) 
respiratory abnormality (respiration rate >60 per minute, 
dyspnea, apnea, increased oxygen demand or treatment with 
mechanical ventilator), 4) metabolic acidiosis (arterial blood 
gas analysis: pH <7.35, base deficit ≥6), 5) gastrointestinal 
tract abnormality (vomiting, abdominal distension, abnormal 
gastric intolerance, bloody stool and umbilical erythema), 6) 
neurological abnormality (drowsiness, muscle weakness, ex-
cessive irritability and convulsion). In addition, gestational 
age, birth weight, delivery type, Apgar score, blood test 
[CRP, white blood cell (WBC)], and culture, use of mechan-
ical ventilator were examined in preterm infants. Neonatal 
hematologic test was performed at 6 hours after birth. We 
started ampicillin and gentamycin treatment in newborns 
with clinical signs18,19 [difficulty feeding, convulsion, move-
ment only when stimulated, repiratory rate ≥60, severe chest 
indrawing, axillary temperature ≥37.5°C, axillary tempera-
ture <35.5°C, the time of premature rupture of membrane 
(PROM) ≥18 hrs, intrapartum fever ≥38°C and suspected 
infection] and positive hematologic results (for example, 
WBC & CRP increased, platelet decreased <150000) as de-
termined by the clinician at hospital day 1.20 We treated an-
tibiotics in sepsis group (n=51) and control group (n=33).
According to the materal infectious condition, 126 moth-
ers were classified as histological chorioamnionitis (44 cas-
es), clinical chorioamnionitis (15 cases), and other infec-
tions group (5 cases) such as intrapartum fever, urinary tract 
infection, enteritis, and other systemic infectious diseases; 
and control group (62 cases). Histolgical chorioamnionitis 
was defined as pathological changes of infection in amnion, 
chorio-decidua, umbilical cord, or chorionic plate tissues.21 
Clinical chorioamnionitis6 was defined by >2 of 6 signs: 1) 
fever >38°C, 2) hysteralgia, 3) fetal tachydardia (>160 times/ 
minute), 4) maternal tachydardia (>100/minute), 5) malodor-
ous vaginal discharge, 6) increased WBC count (≥12000/ 
mm3). Other infection group was 5 cases: vaginitis caused 
by candida (1 case), respiratory infection symptoms (2 cas-
es), and enteritis with vomiting and diarrhea (1 case). Moth-
er’s age, past parous history, gestation age, presence or ab-
sence of PROM, delivery method, blood test (CRP, complete 
blood count, culture and others), histological findings of the 
placenta, cervice culture, amniocentesis, and prenatal use of 
antibiotics were recorded. 
The Receiver Operating Characteristic (ROC) plot22,23 de-
sis, pneumonia, dyspnea, and death rate by 2 to 4 times.7,8 
Early-onset sepsis is associates with an increased risk of 
RDS, bronchopulmonary dysplasia, severe intraventricular 
hemorrhage or periventricular leukomalacia,9 and transfu-
sion.10 The effect of risk of intrauterine infection on fetus 
and neonate is higher than on the mother.11
Simple, rapid, noninvasive, and safe tests of markers of 
intrauterine infection could be useful in prediction of mor-
bidity among pregnant women, with or without labor. If ma-
ternal infections during pregnancy are diagnosed and treated 
early, the mortality and morbidity of neonates should be de-
creased. 
In the literature, several diagnostic methods of peripartum 
intrauterine infection have been considered. There are amni-
onic fluid culture, procalcitonin, C-reactive protein (CRP) in-
terleukin (IL)-6, IL-8, IL-10, IL-18, tumor necrosis factor-al-
pha (TNF-alpha), interferon gamma, and others.12 Of them, 
maternal CRP has been reported to be valuable for early de-
tection of neonatal sepsis.13,14 Conflicting results on use of 
maternal CRP in prediction of neonatal sepsis have been re-
ported.15,16 
 The objective of the study is to determine the accuracy 
of maternal serum CRP in prediction of neonatal sepsis. 
MATERIALS AND METHODS
　　　
We studied the preterm infants (<37 wk) who were admitted 
to the neonatal intensive care unit, Severance Hospital, from 
January 2001 to June 2003. We choosed the preterm infants 
(n=236) and their mothers (n=210) who were examined 
both a laboratory test and placental pathology in peripartum 
period. We excluded twins (n=52) and preterm infants who 
have anormaly, metabolic disease, chromosome and genetic 
disease. Also, we excluded their mothers who have maternal 
eclampsia, preeclampsia, hepatitis, cardiovascular disease, 
rheumatoid disease, gastroenteric disease like as crhon’s dis-
ease, oncologic disease, polycystic ovary syndrome, and 
connective tissue disease which cause elevated CRP. Final-
ly, one hundred twenty six preterm infants (gestation 32±3.2 
wk, birth weight 1887±623 g,) and their mothers (31±3.6 
years, delivery frequency 2.8±1.5 times) were included. 
Preterm infants were divided into neonatal sepsis group 
(51 cases) and control group (75 cases). Neonatal sepsis was 
defined as proven with positive blood culture (3 cases) and as 
suspected with negative blood culture, but more than 3 cate-
gories of positive clinical signs among 6 categories within 3 
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the sepsis group was significantly higher than controls (Table 
1). The maternal CRP of neonatal sepsis group was 3.03 
(±2.93) mg/dL, significantly higher than controls 0.71 (±0.65), 
p-value was <0.001. In the neonatal sepsis group, histologi-
cal chorioamnionitis was more frequent than controls; clini-
cal chorioamnionitis, other infection group, and the use an-
tibiotics were higher in sepsis than controls, but was not 
statistically significant (Table 2). The mortality rate was 6 
among total 126 cases (4.8%), and were all in the sepsis 
group (51 cases), or 12.8% (6 cases/51 cases).
 
picts the relation of sensitivity and specificity of maternal 
CRP to neonatal sepsis. The ROC cutoff value in our study 
subjects was maternal CRP 1.22 mg/dL with sensitivity 71% 
and specificity 84%. Based on this value, We defined ma-
ternal CRP positive group as CRP ≥1.22 mg/dL and mater-
nal CRP negative group CRP <1.22 mg/dL (Fig. 1). Clinical 
characteristics of these two groups was compared in rela-
tion to neonatal sepsis, histological chorioamnionitis, clini-
cal chorioamnionitis and other infection groups.
CRP was measured by nephlometry using the Beckman 
Array System protein analyzer (Global Medical Instrumen-
tation, Inc., Ramsey, MN, USA). 
Statistical analysis
For data analysis, SAS v9.2 was used. Student t-test and Fish-
er’s exact test were used for comparison of two variables. The 
relative risk of neonatal sepsis according to maternal infec-
tion status, and maternal CRP positive group versus negative 
group, were analyzed by logistic regression. Statistical sig-
nificance was defined as p-value <0.05. 
RESULTS
 
Comparison of neonatal sepsis and control groups
In the neonatal sepsis group, gestational age was lower than 
controls. Neonatal CRP performed on day of admission in 
Table 1. Characteristics of Newborns with Neonatal Sepsis 
Neonatal sepsis (n=51) Control (n=75) p value
G.A. (wk) 30.5±3.7 33.2±2.6 <0.001
B.W. (g)   1833±1743 2073±586 NS
WBC (mm3)* 15934±9636 11778±5281   0.006
CRP (mg/dL)†   0.40±0.80   0.20±0.21   0.027
NS, not significant; WBC, white blood cell; CRP, C-reactive protein; G.A., gestational age; B.W., birth weight; SD, standard deviation.
Data mean±SD.
*At birth, WBC. 
†At birth, CRP. 
Table 2. Demographic Characteristics of Mothers with Neonatal Sepsis 
Neonatal sepsis (n=51) Control (n=75) p value
Histologic chorioamnionitis 28 (54%) 16 (21%) <0.001
Clinical chorioamnionitis   6 (11%)   9 (12%) NS
Other infection 2 (4%) 3 (4%) NS
Antibiotics use 24 (47%) 28 (37%) NS
Maternal
    WBC (mm3) 13340±4413 10199±3655 <0.001
    CRP (mg/dL)   3.03±2.93   0.71±0.65 <0.001
NS, not significant; WBC, white blood cell; CRP, C-reactive protein; SD, standard deviation.
Data mean±SD.
Fig. 1. Cutoff  value determined by Receive Operating Characteristic (ROC) 
curves: sensitivity 71%, specificity 84%. 
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in neonatal sepsis. In our study, maternal CRP in neonatal 
sepsis group was significantly higher compared with con-
trols, reflecting maternal effects on neonatal infection.
Among neonatal sepsis group, blood cultures during hos-
pitalization was confirmed in 3 cases. In the other 48 cases, 
sepsis was defined by clinical criteria, and blood culture was 
negative. Clinician were not aware of maternal CRP values. 
Generally, regarding clinical signs of sepsis, the first signs 
appeared within 12 hours of birth and in order of frequency, 
was respiratory distress, cardiovascular (hypotension), and 
temperature abnormality, for >1 hour. Digestive and neuro-
logical abnormality signs occurred 3 days after birth. 
By ROC curve, the sensitivity and specificity of maternal 
CRP for neonatal sepsis in our data (1.22 mg/dL as cutoff 
point), was 71% and 84%, respectively. Sensitivity and spec-
ificity were improved compared with past reports; the cut-
off value of CRP 0.7 mg/dL26 was 56% sensitivity and 77% 
specificity, and using 1.2 mg/dL,27 it was 56% sensitivity, 
76% specificity. Recently Celik, et al.28 reported that the 
cutoff value of CRP 0.48 mg/dL was 67% sensitivity and 
97% specificity. Based on this, in maternal CRP positive 
group, neonatal sepsis incidence occurred in 71%, signifi-
cantly higher than CRP negative group. Maternal WBC, and 
mean value of CRP were significantly higher than CRP 
negative group. 
The frequency of maternal histological chorioamnionitis 
was significantly higher in neonatal sepsis group, and ma-
Maternal characteristics by maternal CRP
The maternal CRP positive compared with negative group 
had more histologic chorioamnionitis and increased WBC 
count (Table 3). 
Relative risk of neonatal sepsis
In comparison with the negative group, the relative risk of 
the maternal CRP positive group for neonatal sepsis was 
10.7, (95% confidence interval 4.3-26.4) with p-value of 
0.001 (Table 4). 
DISCUSSION
In this study, we found that maternal positive CRP is a risk 
factor for neonatal sepsis. CRP is an acute phase protein 
produced in the liver, and has the characteristics of reaching 
maximal concentration 48 hours after stimulation from cy-
tokines, IL-1, TNF, and particularly IL-6, and decreases to 
half after 8 or 9 hours. CRP is increased significantly in 
cases with infection, inflammatory reaction, tissue damage, 
and tissue necrosis.24 CRP maintains a constant value re-
gardless of the gestation period in pregnancy,25 significantly 
elevated maternal CRP implies maternal infection and its 
associated neonatal infection.7 Yoon, et al.7 have reported 
that maternal WBC and CRP were significiantly increased 
not only in amniotic fluid culture positive subjects but also 
Table 3. Maternal Characteristics by Maternal CRP 
Positive maternal CRP (n=48)* Negative maternal CRP (n=78)† p value
Hiotologic chorioamnionitis 24 (50%) 20 (26%) 0.014
Clinical chorioamnionitis   9 (19%) 6 (8%) NS
Other infection 2 (4%) 3 (4%) NS
Maternal 
    WBC (mm3) 13278±4738 10357±3517 <0.0001
    CRP (mg/dL)   3.55±2.69   0.48±0.31 <0.0001
NS, not significant; WBC, white blood cell; CRP, C-reactive protein; SD, standard deviation.
Data mean±SD.
*Cutoff value for positive maternal CRP: ≥1.22 mg/dL. 
†Cutoff value for negative maternal CRP: <1.22 mg/dL. 
Table 4. Relative Risk of Maternal CRP for Neonatal Sepsis 
Positive maternal CRP 
(n=48)*
Negative maternal CRP 
(n=78)†
Odds ratio (95% CI) p value
Neonatal
    Sepsis (+) (n=51)     36 (70.6%)    15 (29.4%) 10.68 (4.313-26.428) <0.001
    Sepsis (-) (n=75) 12 (16%) 63 (84%)
CI, confidence interval; CRP, C-reactive protein.
*Cutoff value for positive maternal CRP: ≥1.22 mg/dL. 
†Cutoff value for negative maternal CRP: <1.22 mg/dL.
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ternal CRP positive group. Thus, maternal infection was as-
sociated with increased neonatal sepsis and maternal CRP. 
In maternal CRP positive group, the relative risk of neona-
tal sepsis was 10.7 times greater than the negative group 
(p<0.001). Neonatal sepsis can be predicted by maternal 
CRP. Therefore, active treatment of mothers before deliv-
ery, intensive follow up observation, and treatment of neo-
nates after delivery should decrease the morbidity and mor-
tality of disease. 
In conclusion, maternal positive CRP is a significant risk 
factor for neonatal sepsis.
Maternal CRP ≥1.22 mg/dL has 71% predictability for 
diagnosis of neonatal sepsis. Therefore, through the simple 
maternal CRP test prior to delivery, the risk level of early 
neonatal sepsis could be predicted. 
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